Product Liability

GLP-1 Receptor Agonists (Ozempic, Wegovy) Gastroparesis Litigation

GLP-1 Receptor Agonists (Ozempic, Wegovy) Gastroparesis Litigation — Product Liability class action lawsuit

Case Overview

This emerging multidistrict litigation (MDL) involves claims from users of GLP-1 receptor agonist drugs, such as Ozempic, Wegovy, and Mounjaro, who allege they developed a severe medical condition known as gastroparesis, or "stomach paralysis." These drugs, wildly popular for diabetes management and weight loss, work by slowing down digestion, which helps control blood sugar and creates a feeling of fullness.

However, plaintiffs in the lawsuit claim that for some individuals, this effect is far more extreme and persistent, leading to a chronic condition where the stomach cannot empty itself properly. Symptoms include severe nausea, vomiting, abdominal pain, and malnutrition. The lawsuits allege that the drug manufacturers, Novo Nordisk and Eli Lilly, failed to adequately warn patients and the medical community about the risk of developing severe or long-lasting gastroparesis.

Frequently Asked Questions

Can I sue Novo Nordisk or Eli Lilly for gastroparesis caused by Ozempic or Wegovy?

Yes, if you developed gastroparesis after using Ozempic, Wegovy, or other GLP-1 receptor agonists, you may have grounds for a product liability lawsuit against the manufacturers. You can join the class action litigation if you meet the eligibility requirements, which typically include having a gastroparesis diagnosis following use of these medications.

How do I get money from a GLP-1 gastroparesis settlement?

If you're a class member and a settlement is reached, you can file a claim with the settlement administrator. You'll typically need to submit proof of your Ozempic or Wegovy use and gastroparesis diagnosis. Once approved, you'll receive your settlement award from the fund established by the defendants.

What symptoms of gastroparesis qualify for the GLP-1 drug lawsuit?

Gastroparesis symptoms that may qualify include severe stomach paralysis, nausea, vomiting, bloating, and difficulty digesting food after taking Ozempic, Wegovy, or similar GLP-1 drugs. Medical records documenting your diagnosis and its timing in relation to medication use are important for your claim.

Related Cases

Roblox Addiction Lawsuit Investigation — Product Liability class action lawsuit

Roblox Addiction Lawsuit Investigation

Current
Product Liability
Attorneys are investigating claims that Roblox was designed to encourage compulsive play, leading to addiction and various harms in children. Parents of affected children may be able to pursue legal action.
GM Sierra, Silverado Transmission Defect Class Action — Product Liability class action lawsuit

GM Sierra, Silverado Transmission Defect Class Action

Current
Product Liability
A class action lawsuit alleges that General Motors sold pickup trucks equipped with a defective transmission and concealed the problem from consumers for years. The suit covers specific GMC and Chevrolet models from the 2019 model year onward.
Abbott Spinal Cord Stimulator Lawsuit — Product Liability class action lawsuit

Abbott Spinal Cord Stimulator Lawsuit

Current
Product Liability
A lawsuit alleges that spinal cord stimulation (SCS) devices manufactured by Abbott can malfunction, potentially leading to permanent nerve damage. The complaint details claims of defective leads and implantable pulse generators that fail over time.